Combination Drug Targets Core Pathologies of ALS Parkinson’s and Alzheimer’s with Alon Ben-Noon NeuroSense Therapeutics TRANSCRIPT
Download PDFApr 25, 2024
Alon Ben-Noon, CEO and board member of NeuroSense Therapeutics, is taking a unique approach to treating neurodegenerative diseases by targeting core pathologies and combining molecules to address various mechanisms. NeuroSense has seen positive clinical trial results for ALS using their lead compound PrimeC, which...
Apr 25, 2024
Alon Ben-Noon, CEO and board member of NeuroSense Therapeutics, is taking a unique approach to treating neurodegenerative diseases by targeting core pathologies and combining molecules to address various mechanisms. NeuroSense has seen positive clinical trial results for ALS using their lead compound PrimeC, which...
Digital Assessments Offer Insight into Brain Performance and Cognitive Health with Dr. John Showalter Linus Health TRANSCRIPT
Download PDFFeb 26, 2024
Dr. John Showalter, Chief Product Officer of Linus Health, shines a light on the current methods of measuring cognitive health and emphasizes the need for a more holistic approach to assessing brain health. Linus works on digital cognitive assessment tools and AI models to detect cognitive impairment and early warning...
Feb 26, 2024
Dr. John Showalter, Chief Product Officer of Linus Health, shines a light on the current methods of measuring cognitive health and emphasizes the need for a more holistic approach to assessing brain health. Linus works on digital cognitive assessment tools and AI models to detect cognitive impairment and early warning...
Next-Generation Schizophrenia Therapy New Chemical Entity for Acute Condition and Maintenance with Laxminarayan Bhat Reviva Pharmaceuticals TRANSCRIPT
Download PDFFeb 6, 2024
Laxminarayan Bhat, Founder, President, and CEO of Reviva Pharmaceuticals, is focused on developing next-generation therapies for neurological diseases, particularly schizophrenia. Their lead candidate, brilaroxazine, acts on multiple neuro receptors to balance imbalanced neurotransmitters in the brain that are...